These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 4147710)
1. Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics. Ananth JV; Ban TA; Lehmann HE Can Psychiatr Assoc J; 1973 Oct; 18(5):377-83. PubMed ID: 4147710 [No Abstract] [Full Text] [Related]
2. The use of nicotinic acid and pyridoxine in the treatment of schizophrenia. Petrie WM; Ban TA; Ananth JV Int Pharmacopsychiatry; 1981; 16(4):245-50. PubMed ID: 7040274 [TBL] [Abstract][Full Text] [Related]
3. Nicotinic acid in the treatment of schizophrenias. Practical and theoretical considerations. Ban TA Neuropsychobiology; 1975; 1(3):133-45. PubMed ID: 8743 [TBL] [Abstract][Full Text] [Related]
4. Negative findings with nicotinic acid in the treatment of schizophrenias. Ban TA Int Pharmacopsychiatry; 1974; 9(3):172-87. PubMed ID: 4430570 [No Abstract] [Full Text] [Related]
5. Nicotinic acid in the prevention and treatment of methionine-induced exacerbation of psychopathology in schizophrenics. Ananth JV; Ban TA; Lehmann HE; Bennett J Can Psychiatr Assoc J; 1970 Feb; 15(1):15-20. PubMed ID: 4906138 [No Abstract] [Full Text] [Related]
6. Niacin in the long-term treatment of schizophrenia. Wittenborn JR; Weber ES; Brown M Arch Gen Psychiatry; 1973 Mar; 28(3):308-15. PubMed ID: 4569673 [No Abstract] [Full Text] [Related]
7. Nicotinic acid in the treatment of schizophrenias. Canadian Mental Health Association collaborative study: progress report II. Ban TA; Lehmann HE Can Psychiatr Assoc J; 1975 Mar; 20(2):103-12. PubMed ID: 1100217 [No Abstract] [Full Text] [Related]
8. Nicotinic acid as adjuvant therapy in newly admitted schizophrenic patients. Ramsay RA; Ban TA; Lehmann HE; Saxena BM; Bennett J Can Med Assoc J; 1970 May; 102(9):939-42. PubMed ID: 4157149 [TBL] [Abstract][Full Text] [Related]
10. Behavioral effects of drug therapy on psychogeriatric inpatients. II. Multivitamin supplement. Altman H; Mehta D; Evenson RC; Sletten IW J Am Geriatr Soc; 1973 Jun; 21(6):249-52. PubMed ID: 4145685 [No Abstract] [Full Text] [Related]
11. Nicotinic acid and nicotinamide in the treatment of chronic schizophrenia. Vallely JF; Lovegrove TD; Hobbs GE Can Psychiatr Assoc J; 1971 Oct; 16(5):433-5. PubMed ID: 4261335 [No Abstract] [Full Text] [Related]
12. Nicotinic acid in the treatment of schizophrenia. Med Lett Drugs Ther; 1973 Dec; 15(26):107-8. PubMed ID: 4271841 [No Abstract] [Full Text] [Related]
16. Piperacetazine in ambulatory chronic schizophrenic patients. Rada RT; Donlon PT Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665 [No Abstract] [Full Text] [Related]
17. Potential value of penfluridol and pipothiazine palmitate. Gallant DM Psychopharmacol Bull; 1975 Jan; 11(1):11-2. PubMed ID: 235769 [No Abstract] [Full Text] [Related]
18. The effect of rubidium in schizophrenia. Chouinard G; Annable L Commun Psychopharmacol; 1977; 1(4):373-83. PubMed ID: 28202 [No Abstract] [Full Text] [Related]
19. A search for responders to niacin supplementation. Wittenborn JR Arch Gen Psychiatry; 1974 Oct; 31(4):547-52. PubMed ID: 4607587 [No Abstract] [Full Text] [Related]
20. [Use of pyridoxine and nicotinic acid in the complex therapy of pulmonary tuberculosis]. Popov GD; Taranenko MI; Luchinskaia LV Probl Tuberk; 1970; 48(9):29-33. PubMed ID: 4253150 [No Abstract] [Full Text] [Related] [Next] [New Search]